ATE245980T1 - Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern - Google Patents

Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern

Info

Publication number
ATE245980T1
ATE245980T1 AT96905942T AT96905942T ATE245980T1 AT E245980 T1 ATE245980 T1 AT E245980T1 AT 96905942 T AT96905942 T AT 96905942T AT 96905942 T AT96905942 T AT 96905942T AT E245980 T1 ATE245980 T1 AT E245980T1
Authority
AT
Austria
Prior art keywords
treatment
pyruvate dehydrogenase
limb ischemia
dehydrogenase activator
activator
Prior art date
Application number
AT96905942T
Other languages
English (en)
Inventor
Dumitru Constantin-Teodosiu
James Archibald Timmons
Paul Leonard Greenhaff
Simon Martin Poucher
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE245980T1 publication Critical patent/ATE245980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT96905942T 1995-03-14 1996-03-11 Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern ATE245980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9505082.9A GB9505082D0 (en) 1995-03-14 1995-03-14 Medicament
PCT/GB1996/000555 WO1996028151A2 (en) 1995-03-14 1996-03-11 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs

Publications (1)

Publication Number Publication Date
ATE245980T1 true ATE245980T1 (de) 2003-08-15

Family

ID=10771147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905942T ATE245980T1 (de) 1995-03-14 1996-03-11 Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern

Country Status (7)

Country Link
EP (1) EP0814801B1 (de)
JP (1) JPH11501653A (de)
AT (1) ATE245980T1 (de)
AU (1) AU4950296A (de)
DE (1) DE69629282T2 (de)
GB (1) GB9505082D0 (de)
WO (1) WO1996028151A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
GB9811932D0 (en) * 1998-06-04 1998-07-29 Zeneca Ltd Chemical compunds
JP2003508509A (ja) 1999-09-04 2003-03-04 アストラゼネカ アクチボラグ ピルビン酸デヒドロゲナーゼの阻害剤としてのアミド
WO2001017956A1 (en) 1999-09-04 2001-03-15 Astrazeneca Ab Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
US6552225B1 (en) 1999-09-04 2003-04-22 Astrazeneca Ab Chemical compounds
KR102739453B1 (ko) 2018-11-14 2024-12-09 (주)아모레퍼시픽 피부 노화 모델의 제조방법, 그 방법에 의해 제조된 피부 노화 모델 및 그 피부 노화 모델을 이용한 항노화 물질의 스크리닝 방법

Also Published As

Publication number Publication date
WO1996028151A3 (en) 1997-01-23
GB9505082D0 (en) 1995-05-03
EP0814801B1 (de) 2003-07-30
EP0814801A2 (de) 1998-01-07
DE69629282T2 (de) 2004-04-22
WO1996028151A2 (en) 1996-09-19
DE69629282D1 (de) 2003-09-04
AU4950296A (en) 1996-10-02
JPH11501653A (ja) 1999-02-09

Similar Documents

Publication Publication Date Title
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
ATE166534T1 (de) Germicide wirkstoffkombinationen
DE60112055D1 (de) Inhibitoren von gamma-secretase
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
CA2256582A1 (en) Oxa acids and related compounds for treating skin conditions
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
NO982721L (no) Preserverende oppl°sning
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
BG101138A (en) The use of glyceryltriacetate for the treatment of onychomycosis
AU5493296A (en) 6-carboxamido dihydropyran derivatives
ATE174786T1 (de) Orale präparate zur behandlung von plaque und gingivitis, die einen nicht-kationischen antibakteriellen wirkstoff und ein bikarbonatsalz enthalten
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
DE69218816D1 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
SE9403831D0 (sv) A storage stable water solution for infusion I
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
DE69708109D1 (de) Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben
TR199900153T2 (xx) H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler.
NO179009C (no) Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
ATE207063T1 (de) Uracilderivate
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
ATE231838T1 (de) N,n'-diacylthiocystine
DE68919301D1 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties